Technical Analysis for BHC - Bausch Health Companies Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Bullish Engulfing | Bullish | -1.88% | |
Wide Bands | Range Expansion | 0.46% | |
Down 3 Days in a Row | Weakness | 0.46% | |
MACD Bearish Signal Line Cross | Bearish | -0.73% | |
Wide Bands | Range Expansion | -0.73% | |
Overbought Stochastic | Strength | -0.73% | |
Slingshot Bullish | Bullish Swing Setup | -1.79% | |
Wide Bands | Range Expansion | -1.79% |
Alert | Time |
---|---|
Possible Inside Day | 2 days ago |
20 DMA Support | 2 days ago |
Down 2% | 2 days ago |
Down 1% | 2 days ago |
Fell Below 10 DMA | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 2024-10-30
Bausch Health Companies Inc. Description
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health S&P/Tsx 60 Index Medicine Pharma Pharmaceutical Biotechnology Pharmaceuticals Pharmaceutical Products Laser Medical Devices Atopic Dermatitis Contact Lens Psoriasis Ulcer Ulcerative Colitis Aes Dermatology Specialty Drugs Acne Actinic Keratosis Colitis Hair Removal Irritable Bowel Syndrome Keratosis Over The Counter Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.43 |
52 Week Low | 5.45 |
Average Volume | 384,422 |
200-Day Moving Average | 10.401 |
50-Day Moving Average | 9.146 |
20-Day Moving Average | 10.883 |
10-Day Moving Average | 11.092 |
Average True Range | 0.337 |
RSI (14) | 62.55 |
ADX | 40.61 |
+DI | 32.348 |
-DI | 15.517 |
Chandelier Exit (Long, 3 ATRs) | 10.520 |
Chandelier Exit (Short, 3 ATRs) | 9.520 |
Upper Bollinger Bands | 11.762 |
Lower Bollinger Band | 10.004 |
Percent B (%b) | 0.54 |
BandWidth | 16.154 |
MACD Line | 0.534 |
MACD Signal Line | 0.620 |
MACD Histogram | -0.0855 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 11.370 | ||||
Resistance 3 (R3) | 11.393 | 11.277 | 11.300 | ||
Resistance 2 (R2) | 11.277 | 11.170 | 11.265 | 11.277 | |
Resistance 1 (R1) | 11.113 | 11.104 | 11.055 | 11.090 | 11.253 |
Pivot Point | 10.997 | 10.997 | 10.968 | 10.985 | 10.997 |
Support 1 (S1) | 10.833 | 10.890 | 10.775 | 10.810 | 10.647 |
Support 2 (S2) | 10.717 | 10.824 | 10.705 | 10.623 | |
Support 3 (S3) | 10.553 | 10.717 | 10.600 | ||
Support 4 (S4) | 10.530 |